Stockwinners Market Radar for July 19, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:06 EDT Cathie Wood's ARK Investment bought 214.2K shares of Zymergen today

20:05 EDT Cathie Wood's ARK Investment bought 214.2 shares of Zymergen today

18:46 EDT Netflix plans to spend roughly $17B on content over next few years - Says margin to "hold flat" until revenue grows.

18:33 EDT Netflix plans wider rollout for paid sharing next year - Says "vast majority" of what people watch on Netflix could be in ad-supported tier today.

18:22 EDT Netflix says negotiating for rights to put ads in other shows - Says ad-supported program consistent with "pro-consumer" pricing tier strategy. Says ad experience will differ from traditional TV. Says ad tier could be "expansive" and "neutral to positive" from a unit economics standpoint.

18:06 EDT Albertsons recalls select ReadyMeals seafood products - Albertsons has voluntarily recalled three ReadyMeals seafood items prepared in store due to allergens not listed on the ingredient labels. The recall was initiated after an internal technical review identified missing ingredients containing allergens. There have been no reports of injuries or adverse reactions due to consumption of these products. Anyone concerned about an injury or illness should contact a healthcare provider. The select ReadyMeals seafood items were available for purchase at the following Albertsons Cos. store banners: ACME, Albertsons, Andronico's Community Markets, Balducci's, Carrs-Safeway, Eagle, Jewel-Osco, King's, Pak 'N Save, Safeway, Shaw's, Star Market and Vons.

17:56 EDT Hippo to complete reverse stock split in ratio range of 1-for-20 to 1-for-30 - Hippo Holdings intends to file a proxy statement with the Securities and Exchange Commission in connection with a special meeting of stockholders to be held on August 31. The proxy statement will include a proposal for a reverse stock split at a ratio in the range of 1-for-20 to 1-for-30 and the reduction of the number of authorized shares of capital stock of the company by a corresponding proportion. The reverse stock split to be proposed to Hippo stockholders in the proxy statement is intended to resolve the issue raised in a non-compliance notice Hippo received from the New York Stock Exchange on July 19 regarding Section 802.01C of the NYSE Listed Company Manual due to the average closing price of the company's common stock being less than $1.00 over a consecutive 30 trading-day period. The notification has no immediate effect on the listing or trading of Hippo's common stock on the NYSE. Hippo can regain compliance at any time within the six-month period following receipt of the NYSE notice if on the last trading day of any calendar month during the cure period the company has a closing price of at least $1.00 per share and an average closing price of at least $1.00 per share over the 30-trading day period ending on the last trading day of that month.

17:34 EDT Vale updates FY22 iron ore and copper production estimates - Vale updates FY22 iron ore and copper production estimates. The company see FY22 iron ore production 310Mt-320Mt and copper production of 310kt-320kt. Reference Link

17:03 EDT East Resources Acquisition enters LOI for combination with asset manager - East Resources Acquisition announced that it has entered into a non-binding letter of intent, or LOI, for a business combination with a vertically integrated alternative asset manager specializing in specialty insurance products, with a focus on origination, asset management, valuation and servicing. The target has an experienced management team. Under the terms of the LOI, the company and target would become a combined entity, with the Target's existing equityholders rolling over 100% of their equity into the combined public company. The company expects to announce additional details regarding the proposed business combination when a definitive agreement is executed, which is expected later in the third quarter. Any transaction would be subject to board and equityholder approval of both companies, regulatory approvals and other customary conditions. The company is holding a special meeting of its stockholders on July 25 to extend the date by which the company must consummate a business combination from July 27 to January 27, 2023, and the proposed transaction would be subject to approval of such proposal by the company's stockholders.

16:55 EDT FDA evaluating agency's programs and oversight after Juul, baby formula issues - FDA evaluating agency's programs and oversight after Juul, baby formula issues. The FDA's Commissioner of Food and Drugs Robert Califf, M.D., MACC said, in part: "In February 2022, I rejoined the U.S. Food and Drug Administration as Commissioner of Food and Drugs, having served in the role five years earlier...the agency has confronted a series of challenges that have tested our regulatory frameworks and stressed the agency's operations, prompting me to take a closer look at how we do business. As a result, for two of the agency's key programs, I have commissioned external agency experts to conduct a comprehensive evaluation for: The agency's Human Foods Program, including the Office of Food Response and Policy, OFPR, Center for Food Safety and Applied Nutrition CFSAN, as well as relevant parts of the Office of Regulatory Affairs, ORA. While America's food supply is safe, and our Foods program experts have significantly contributed to the availability of more nutritious food options for consumers...Fundamental questions about the structure, function, funding and leadership need to be addressed...Just over 13 years ago, Congress tasked the FDA with regulating tobacco products. In the ensuing years, we have made important progress and reached regulatory decisions on a broad array of millions of products. But even greater challenges lie ahead as we determine how the agency will navigate complex policy issues and determine enforcement activities for an increasing number of novel products that could potentially have significant consequences for public health." Companies in the tobacco space include British American Tobacco (BTI), Altria Group (MO) and Imperial Brands (IMBBY). Companies that make 'baby formula' include Abbott (ABT) and Reckitt Benckiser (RBGPF). Reference Link

16:33 EDT Inozyme announces preliminary biomarker, safety and PK data from INZ-701 trial - Inozyme announced preliminary biomarker, safety, and pharmacokinetic, or PK, data from the first three subjects treated in the Phase 1 portion of its ongoing Phase 1/2 clinical trial of INZ-701 in adult subjects with ABCC6 Deficiency, which presents as pseudoxanthoma elasticum, or PXE, in older individuals. At the 0.2 mg/kg dose level of INZ-701, all three subjects showed rapid and significant increases in PPi levels. In preclinical models, PPi was shown to be a predictive biomarker of therapeutic benefit in ABCC6 Deficiency. The mean PPi level across the three subjects at baseline was 851 nM. The mean PPi level during the 32-day dose evaluation period across the three subjects was 1057 nM, which was within the range observed in the company's study of healthy subjects. Among the three subjects, the range of peak PPi levels observed during the 32-day dose evaluation period was 2139-4090 nM. Preliminary PK and INZ-701 enzymatic activity remained consistent with data previously reported from the company's ongoing Phase 1/2 trial of INZ-701 in subjects with ENPP1 Deficiency. INZ-701 continued to exhibit a favorable initial safety profile. INZ-701 was generally well-tolerated with no serious adverse events, or SAEs, reported, one grade 1 adverse event, or AE, and no injection site reactions. The grade 1 AE was not related to INZ-701. Low titers of anti-drug antibodies, or ADAs, were observed in one subject at day 32 of the trial, which had no impact on PK or ENPP1 activity. All three subjects from the first cohort enrolled in the open-label Phase 2 48-week extension portion of the trial. Following the planned review of these preliminary data by a data safety monitoring board, or DSMB, Inozyme expects to initiate dosing in the next dose cohort in this trial in the third quarter. The company plans to report topline data from the ongoing Phase 1/2 clinical trial in ABCC6 Deficiency in the first quarter of 2023.

16:30 EDT Vascular Biogenics trading resumes

16:22 EDT UnitedHealth CEO sells $6.0M in common stock - In a regulatory filing, UnitedHealth disclosed that its CEO Andrew Witty sold 11.4K shares of common stock on July 18th in a total transaction size of $6.0M.

16:21 EDT Thorne HealthTech achieves self-affirmed GRAS for NRM product - Thorne HealthTech announced that it has achieved self-affirmed GRAS status for its proprietary nicotinamide riboside malate product. Under the Federal Food, Drug and Cosmetic Act, GRAS is a regulatory classification term used to identify a food ingredient that is generally recognized among qualified experts as having been adequately shown to be safe under the conditions of its intended use. Self-affirmed GRAS status requires that an ingredient undergo extensive quality and safety testing, as well as review by an independent outside expert panel. Based on extensive analysis, Thorne's NRM has been established as having a quality, safety, and purity profile equal to or superior to other forms of nicotinamide riboside currently on the market.

16:19 EDT DCP Midstream raises Q2 cash distribution 10% to 43c per unit - DCP Midstream announced that the board of directors of its general partner declared a second quarter 2022 Common Unit cash distribution of 43c per unit, or $1.72 per unit on an annualized basis. This quarterly Common Unit distribution represents a 10% increase over the prior quarter's distribution and will be paid August 12 to common unitholders of record at the close of business on July 29.

16:17 EDT Core & Main to acquire inland Water Works Supply Co. - Core & Main "has entered into a definitive agreement to acquire substantially all of the assets of Inland Water Works Supply Co., a full-service distributor of water and wastewater products, based in Southern California."

16:15 EDT JPMorgan names J&J executive chairman Alex Gorsky to board of directors - JPMorgan Chase (JPM) announced that Alex Gorsky has been elected director of the company, effective immediately. Gorsky serves as Executive Chairman of Johnson & Johnson (JNJ). He previously served as Chairman and Chief Executive Officer of the company from 2012-2021. Under his leadership, Johnson & Johnson has become one of the world's largest healthcare companies and one of the foremost innovators in research and development for emerging health technologies. His influence has shaped both the healthcare landscape and the greater business community through his work as a member of the Business Roundtable and on the Business Council. He currently sits on the boards of Apple, Inc., IBM, New York-Presbyterian Hospital, and the Travis Manion Foundation, and serves on the Wharton School of the University of Pennsylvania Board of Advisors.

16:12 EDT Rocky Mountain Chocolate issues letter to stockholders regarding proxy fight - Rocky Mountain Chocolate issued the following press release and letter to stockholders of the company: "Rocky Mountain Chocolate Factory Inc.'s ("RMCF") 2022 Annual Meeting of Stockholders is scheduled to be held on August 18. Your vote on the WHITE proxy card is particularly important this year since your Board's and management team's efforts to turn around RMCF and restore stockholder value are threatened by yet another costly and distracting proxy fight by the AB Value and Bradley Radoff group ("AB Value"). RMCF's business, under the direction of a refreshed Board and a new hard-charging CEO, is now stronger than it was pre-COVID 19. Our franchisees weathered the storm quite well and most are posting stronger sales levels than pre-COVID. Inflationary and supply chain pressures, which have adversely impacted many consumer facing businesses, have been minimal, offset by sustained consumer purchases, targeted price increases, and a captive and efficient supply and distribution network. Yet, for the third time in four years, AB Value is waging another costly, disruptive proxy fight by nominating two director candidates for election at this year's annual meeting, despite the fact that two of our six director nominees on the WHITE proxy card were previously nominated by AB Value. The election of their two new nominees would not just disrupt our program to turn around RMCF, but would give AB Value representation on our Board far disproportionate to their stock ownership and far, far more than any other stockholder. Please support your Board's efforts to turn around RMCF and deliver superior value for the benefit of all stockholders by signing, dating, and returning the enclosed WHITE proxy card with a vote FOR the election of all our nominees and FOR the other proposals..."

16:11 EDT Netflix says near-term priority to re-accelerate revenue growth - Netflix said: "In the near term, a key priority to re-accelerate revenue growth is to evolve and improve our monetization. In the early days of streaming, we kept our pricing very simple with just one plan level. In 2014, we introduced three price tiers to better segment demand. Going forward, we will focus on better monetizing usage through both continued optimization of our pricing and tiering structures as well as the addition of a new, lower-priced ad-supported tier. Our lower priced advertising-supported offering will complement our existing plans, which will remain ad-free. Our global ARM has grown at a 5% compound annual rate from 2013 to 2021, so it makes sense now to give consumers a choice for a lower priced option with advertisements, if they desire it."

16:10 EDT Netflix says 'need to continue to improve all aspects of Netflix' - Netflix stated: "Last quarter, we discussed our slowing revenue growth, which we believe is the result of connected TV adoption, account sharing, competition, and macro factors such as sluggish economic growth and the impacts of the war in Ukraine. We've now had more time to understand these issues, as well as how best to address them. First and foremost, we need to continue to improve all aspects of Netflix. This focus on improving our core service has served us well over the past 25 years, and remains our north star to drive continuous growth. It's why we strive for an ever better content, marketing and product experience. Also as a pure play streaming business, we're unencumbered by legacy revenue streams. This freedom means we can offer big movies direct-to-Netflix, without the need for extended or exclusive theatrical windows, and let members binge watch TV if they want, without having to wait for a new episode to drop each week. This focus on choice and control for members influences all aspects of our strategy, creating what we believe to be a significant long term business advantage."

16:08 EDT Omnicom CEO says 'strong financial position' entering 2H22 - "We performed well on every metric this quarter, led again by double-digit organic revenue growth," said John Wren, Chairman and CEO of Omnicom Group Inc. "The changes we have made in our portfolio are delivering better results for our clients as we are uniquely qualified to help them digitally transform their business, navigate complexity, and expand in high-growth areas like retail media and e-commerce. As we enter the second half of the year, we are in a strong financial position, and our company is well-prepared to manage through economic headwinds."

16:08 EDT Forestar Group sees FY22 pre-tax margin roughly 14.25% - Donald J. Tomnitz, Chairman of the Board, said, "Based on our fiscal year-to-date results and current market conditions, including development delays and moderation in housing demand, we are updating our guidance for fiscal 2022. We now expect our pre-tax profit margin for the full fiscal year to be approximately 14.25% compared to our prior guidance of 14.0% to 14.5%. Additionally, we expect to deliver approximately 17,000 lots generating approximately $1.425 billion of revenue in fiscal 2022, compared to our prior guidance of between 19,500 and 20,000 lots generating approximately $1.7 billion of revenue. Forestar's return-focused business model is centered on our high inventory turnover, low risk lot manufacturing strategy. Our liquidity and balance sheet strength enables us to effectively operate through changing economic conditions and positions us to be opportunistic when attractive opportunities present themselves. We expect continued profitable growth in the coming years, supported by our low net leverage, the engagement of our people, our strategic relationship with D.R. Horton and 97,000 lots owned and controlled at June 30, 2022."

16:03 EDT Netflix sees Q3 global streaming paid net additions of 1.0M members - Netflix said in its quarterly letter to investors: "Our Q3 revenue growth forecast of 5% translates into 12% year over year revenue growth on a constant currency basis. Similarly, excluding the impact of currency, operating profit growth would be -3% year over year (vs our forecast decline of -29%) and operating margin would be 20% (vs our forecast of 16%). As we have written in the past, over the medium term, we intend to continue to adjust our business as appropriate given the relative strength of the USD to protect our operating margin and try to avoid immediate actions that we believe could be detrimental to the business. We forecast paid net adds for Q3 of +1.0m vs. 4.4m in the year ago quarter. We continue to expect full year 2022 operating margin of 19%-20%, excluding the unanticipated $150m of restructuring costs in Q2 noted above and the material movement in F/X from January 2022, as our guidance was set based on F/X at that time."

16:00 EDT Vascular Biogenics trading halted, news pending

14:41 EDT SCWorx signs 2-year service agreement extension with 'top 5' IDN in U.S. - SCWorx announced the signing of a 2-year service agreement extension with "a highly respected Integrated Delivery Network, or 'IDN,' ranked in the Top 5 largest IDN's in the United States," citing the "Definitive Healthcare List: Top 25 IDN by Net Patient Revenue." The company stated: "An integrated delivery network is an organization with a group of allied healthcare providers along with local healthcare facilities. This current customer was previously contracted for a 1-year $450,000 service agreement for SCWorx's data management solutions that repairs and connects supply chain, financial and clinical attributes. This new service agreement is effective January 1, 2022 and will extend the agreement through the end of 2023 and includes additional services for Oracle Cloud. The new service agreement increases our previous anticipated revenue to a total contract value of $960,000 over the term of the new contract, of which $135,000 was recognized in the first quarter of 2022."

14:16 EDT USPTO says Liquidia established United Therapeutics' '793 patent 'unpatentable' - Administrative Patent Judges for the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office stated in a judgement posted to the USPTO site: "Liquidia Technologies, the "Petitioner," filed a Petition requesting an inter partes review of claims 1-8 of U.S. Patent No. 10,716,793 B2, or "the '793 patent," held by patent owner United Therapeutics Corporation. On August 11, 2021, we instituted inter partes review of claims 1-8 of the '793 patent on all grounds set forth in the petition... This is a Final Written Decision under 35 U.S.C. Section 318(a) as to the patentability of the challenged claims of the '793 patent. For the reasons discussed below, we determine Petitioner has established by a preponderance of the evidence that each of claims 1-8 of the '793 patent is unpatentable."

14:02 EDT West Fraser Timber trading resumes

13:50 EDT Pfizer, BioNTech complete submission to EMA for Omicron BA.1 adapted vaccine - Pfizer (PFE) and BioNTech SE (BNTX) announced they have completed a submission to the European Medicines Agency for an Omicron-adapted bivalent COVID-19 vaccine candidate, based on the BA.1 sub-lineage, for individuals 12 years of age and older. This application follows guidance from the EMA and International Coalition of Medicines Regulatory Authorities to work towards introducing an Omicron-adapted bivalent vaccine candidate to address the continued evolution of SARS-CoV-2. The companies' previously announced safety, tolerability and immunogenicity data from a Phase 2/3 trial that found a 30 microgram booster dose of the Omicron-adapted bivalent vaccine candidate elicited a superior immune response against Omicron BA.1 as compared to the companies' current COVID-19 vaccine. The bivalent vaccine candidate was well-tolerated with a favorable safety profile. Pfizer and BioNTech previously shared these data with the U.S. Food and Drug Administration to support a potential variant-adapted vaccine and continue to submit additional data as advised by the agency.

13:39 EDT West Fraser says no buyout proposal received from CVC, Kronospan - West Fraser Timber issued a statement that reads: "The Company is aware of recent market and media speculation. Although the Company has previously met with Kronospan, an existing shareholder, and CVC Capital Partners, the Company has not received a proposal and there are no ongoing discussions regarding the terms of any transaction. The Company is focused on executing on its business strategy to create shareholder value."

12:51 EDT West Fraser Timber trading halted, news pending

12:30 EDT Google to let Euro developers offer alternative billing systems - In a blog post, Google announced a new program to support billing alternatives for European Economic Area users. This will mean developers of non-gaming apps can offer their users in the EEA an alternative to Google Play's billing system when they are paying for digital content and services. "Google has been a leader in platform openness for more than a decade, allowing for multiple app stores and avenues of distribution on Android, and piloting user choice billing," the company said. "We intend to continue these important efforts, while also recognizing that the recent passage of the Digital Markets Act will require Google Play and other industry players to adjust their current operating model for users in the European Economic Area (EEA). We are committed to meeting these new requirements while ensuring that we can continue to keep people safe on our platforms and invest in Android and Play for the benefit of the entire ecosystem." Developers who choose to use an alternative billing system will need to meet appropriate user protection requirements, and service fees and conditions will continue to apply in order to support our investments in Android and Play. When a consumer uses an alternative billing system, the service fee the developer pays will be reduced by 3%. Since 99% of developers currently qualify for a service fee of 15% or less, those developers would pay a service fee of 12% or lower based on transactions through alternative billing for EEA users acquired through the Play platform. Google will not remove, or reject updates of, non-gaming apps from participating developers for offering alternative billing systems for EEA users. Reference Link

12:13 EDT Edgio names Darrin Reynolds Chief Information Security Officer - Edgio (EGIO) announced the appointment of Darrin Reynolds as Chief Information Security Officer. He served as Chief Privacy Officer and the VP of Information Security for the Diversified Agency Services division of Omnicom Group (OMC). Edgio says Reynolds has more than 20 years of information security experience spanning technology, healthcare, pharmaceutical, financial, manufacturing, communications, entertainment and retail industries, helping organizations "realize the benefits of safeguarding and leveraging sensitive data."

12:04 EDT Mattel, Skydance Media to develop Matchbox live-action motion picture - Skydance Media and Mattel announced plans to develop the Matchbox die-cast toy vehicle line into a live-action motion picture. Robbie Brenner, Executive Producer of Mattel Films, said, "We look forward to working with our incredible partners at Skydance Media to craft a story for the big screen that evokes the same, imaginative spirit of this beloved Mattel franchise and delights fans of all ages."

12:00 EDT Direxion Daily Semiconductor Bear 3X Shares falls -10.8% - Direxion Daily Semiconductor Bear 3X Shares is down -10.8%, or -$5.98 to $49.20.

12:00 EDT AMTD Digital falls -34.9% - AMTD Digital is down -34.9%, or -$9.71 to $18.09.

12:00 EDT West Fraser Timber rises 17.8% - West Fraser Timber is up 17.8%, or $14.84 to $98.08.

11:49 EDT Spirit Airlines to add Pilot, Flight Attendant crew base in Houston - Spirit Airlines announced the addition of a new Pilot and Flight Attendant crew base at George Bush Intercontinental Airport. Spirit expects to locate about 150 Pilots and about 300 Flight Attendants in Houston starting this fall, with additional crew, supervisors and support functions to follow. The two investments aim to support the many exciting new destinations coming soon to Spirit's route map and support the airline's growing Fit Fleet, which is one of the youngest and most fuel-efficient fleets in the industry. Spirit plans to accept 24 brand new planes in 2022, bringing its fleet total to 197 aircraft, and 33 more new planes are planned for delivery in 2023.

11:24 EDT AvidXchange enters referral partnership with Member Driven Technologies - AvidXchange Holdings announced a referral partnership with Member Driven Technologies. MDT hosts the Episys core platform from Symitar to provide a private cloud alternative for core processing and IT needs. This partnership will help promote AvidAscend, a best-in-class invoice-to-pay software solution, to MDT's 100+ credit union clients.

11:07 EDT Lockheed Martin sees supply chain challenges continuing for remainder of year - Continues to anticipate annual deliveries of 156 F-35 aircraft beyond 2025 for the foreseeable future. Says operational performance was solid. Says order flow was favorable. Anticipates supply chain challenges to continue for remainder of the year. Says encouraged by support programs have seen in U.S. budget process. Comments taken from Q2 conference call.

10:48 EDT Embraer announces Porter Airlines orders further 20 E195-E2s - Porter Airlines has placed a firm order for 20 Embraer E195-E2 passenger jets, adding to their existing 30 firm orders. Porter will use the E195-E2 to extend its service to destinations throughout North America. The deal, with a list price value of $1.56B, brings Porter's orders with Embraer to a total of up to 100 E195-E2 aircraft, with 50 firm commitments and 50 purchase rights. In 2021, Porter ordered 30 Embraer E195-E2 jets, with purchase rights for a further 50 aircraft, worth $5.82B at list price, with all options exercised. Porter's first delivery and entry into service is scheduled starting in the second half of 2022. Configuration plans for Porter's E2s will be revealed in due course. Michael Deluce, President and CEO of Porter Airlines said, "Embraer has a proven aircraft, representing the best of environmental efficiency, operating performance and passenger comfort. We are in final preparations to introduce the E195-E2 to North America, joining other global airlines already benefiting from its use. The aircraft will become core to our fleet, as Porter reshapes passenger expectations for air travel in same way we did over 15 years ago. Announcements are forthcoming that will detail our initial routes, in-flight product and other details."

10:33 EDT GM Defense to provide batter EV to U.S. Army for analysis, demonstration - GM Defense, a subsidiary of General Motors, was selected by the U.S. Army to provide a battery electric vehicle for analysis and demonstration. GM Defense will leverage the GMC HUMMER EV, featuring GM's Ultium Platform, to meet the U.S. Army's requirement for a light to heavy duty battery electric vehicle to support reduced reliance on fossil fuels both in the operational and garrison environments, the company said in a statement. "This award showcases GM Defense's ability to leverage the best battery electric technology in the commercial marketplace," said Steve duMont, president of GM Defense.

10:16 EDT Acadia Healthcare forms JV with ECU Health to build behavioral health hospital - Acadia Healthcare Company announced that it has formed a joint venture with ECU Health, formerly Vidant Health, eastern North Carolina's premier health system. The new partnership anticipates building a 144-bed behavioral health hospital in the medical district of Greenville, North Carolina. Slated to open in the spring of 2025, the hospital will be operated through the joint venture between ECU Health and Acadia. Together, the organizations will invest approximately $65M in expanding behavioral health resources in eastern North Carolina. The new hospital will also serve as a teaching hospital, training students and residents from the Brody School of Medicine, the companies said.

10:02 EDT Current names Jason Scott Fokens as VP, general counsel - Current announced that Jason Scott Fokens has been named VP, General Counsel. Jason brings more than 25 years of leadership experience in legal, patent and intellectual property to this role. Most recently he served as Head of Legal and Assistant Corporate Secretary at GOJO Industries.

10:00 EDT Permianville Royalty Trust falls -7.2% - Permianville Royalty Trust is down -7.2%, or -27c to $3.40.

10:00 EDT AMTD Digital falls -22.0% - AMTD Digital is down -22.0%, or -$6.12 to $21.68.

10:00 EDT Silvergate Capital rises 17.5% - Silvergate Capital is up 17.5%, or $11.36 to $76.41.

09:58 EDT TriMas trading resumes

09:47 EDT Squarespace falls -6.2% - Squarespace is down -6.2%, or -$1.32 to $20.00.

09:47 EDT Permianville Royalty Trust falls -8.2% - Permianville Royalty Trust is down -8.2%, or -30c to $3.36.

09:47 EDT AMTD Digital rises 16.9% - AMTD Digital is up 16.9%, or $4.69 to $32.49.

09:41 EDT AMTD Digital Inc trading resumes

09:38 EDT Ultragenyx trading resumes

09:34 EDT Chevron, Google invest in TAE Technologies - TAE Technologies announced that it has secured strategic and institutional investments to fund the construction of its next research reactor, Copernicus. TAE has attracted the support of investors and to date has raised a total of $1.2B for its commercial fusion development. In its recently closed Series G-2 financing round, TAE secured $250M from investors in the energy, technology, and engineering sectors to support the company's mission to deliver a long-term solution to rapidly growing electricity demand while providing global energy independence and security. Chevron (CVX), Google (GOOG;GOOGL), Reimagined Ventures, Sumitomo Corporation (SSUMY) of Americas, and TIFF Investment Management are among the company's most recent investors, along with a large U.S. West coast based mutual fund manager and a big U.S. pension fund.

09:33 EDT Ultragenyx trading halted, volatility trading pause

09:29 EDT Seven Arts provides update on uplisting efforts - Seven Arts Entertainment provides a shareholder update on its steps toward up-listing from Pink Alternative Reporting to SEC Reporting. On July 15, 2022, Seven Arts filed an 8k with the Securities and Exchange Commission announcing that the Company has engaged BF Borgers CPA PC to act as the Company's auditor. The Company had determined the 8k filing would be the appropriate first step in establishing a chronology toward its intent of up-listing as an SEC reporter, followed by the filing of a Form 10 and the requisite two years of audited financials. After the recent conclusion of the Company's June 30 fiscal year end, management believes the timing is right in its stated strategy of continuing to resurrect the Seven Arts brand and restoring shareholder value. Up-listing to SEC reporting represents the next logical step toward that objective. The Company will continue to keep shareholders updated on its progress with audited financials as well as its ongoing initiatives in developing its entertainment industry assets. In particular the Company's ongoing negotiations with streaming platforms and larger film studio partnerships, over the days and weeks to come. Stated Seven Arts' CEO, Jason Black: "We continue to advance on everything that has been outlined over the past 12 months and I'm very pleased with our current trajectory. Many are likely unaware that I have prior experience consulting on bringing dormant entities to current SEC reporting. I'm familiar with the audit process and I believe it will go quickly and smoothly. I remain committed on continuing to deliver on the goals I've outlined since taking over at Seven Arts."

09:27 EDT HEICO acquires 96% of Accurate Metal Machining, terms not disclosed - HEICO Corporation announced its Flight Support Group has acquired 96% of Accurate Metal Machining, for cash at closing, plus potential additional cash consideration to be paid if certain post-closing earnings levels are attained. Additional financial details were not disclosed. HEICO stated that it expects the acquisition to be accretive to its earnings within the year following closing. Cleveland-based Accurate Metal Machining is a leading manufacturer of high-reliability components and assemblies. Accurate's customers include large aerospace, defense, and semiconductor equipment subsystem suppliers. These customers operate in markets in which the cost of failure is very high, and as such, purchased components must be made to extremely high reliability and quality standards. Accurate is differentiated in this market by delivering high quality parts, on-time, and at a competitive cost, and has many multi-decade customer relationships that attest to their capabilities. Accurate employs approximately 250 people at its Cleveland production facility. Accurate was founded in 1976 by Louis Loiczly. Louis's four children, Eva, Gabriel, Martha, and Thomas, all work at Accurate and will continue to do so post-close. Accurate's President, John Racic, will continue in his current role with the company. HEICO stated that it does not expect any staff turnover to result from the acquisition. Accurate adds new products and capabilities to HEICO's rapidly-growing and highly-successful Specialty Products Group operations which are dedicated to manufacturing high-reliability, mission-critical components for primarily aerospace and defense customers.

09:22 EDT Verus International enters second distribution agreement in Florida - Verus International announced that it has signed a second distribution agreement in Florida featuring products from its joint venture with Flord, a maker of premium rare cannabinoids. The Company previously announced that it had expanded the JV's offerings into the beverage space in order to provide a more complete selection during the roll-out phase. The official launch date for both online and in store sales of Flord products is August 1st, with preorder available prior to that date.

09:20 EDT Petros Pharmaceuticals signs collaboration agreement with Dr. Pinsky - Petros Pharmaceuticals announces that it has signed a compensated collaboration agreement with physician Dr. Drew Pinsky to raise awareness, foster dialogue, educate, and alleviate the stigma of erectile dysfunction and sexual dysfunction within the men's health and wellness landscape. Through this collaboration, Dr. Drew will expand awareness of Petros Pharmaceuticals' mission in the men's health category and provide greater education around its flagship pharmaceutical therapy STENDRA especially as Petros continues to work with the FDA to pursue Over The Counter designation. "Dr. Drew continues to be a key figure in educating the public regarding sensitive health topics using his unique perspective and public health platform. We believe this social media program will help to further raise Petros's profile in the men's health category, where we have dedicated our resources toward creating a diversified offering of clinically supported options to health problems unique to men, including erectile dysfunction and Peyronie's disease," said Fady Boctor, Petros Pharmaceuticals' President and Chief Commercial Officer.

09:19 EDT American Campus announces ISS recommendation for acquisition of the company - American Campus announced that a independent proxy advisory firm, Institutional Shareholder Services, or ISS, has recommended that stockholders vote for the previously announced all-cash acquisition of the company by Blackstone Core+ perpetual capital vehicles, primarily comprised of Blackstone Real Estate Income Trust, alongside Blackstone Property Partners, at the company's upcoming special meeting of stockholders scheduled for August 4.

09:17 EDT Monarch provides results from 2021-2022 program on its Swanson gold project - Monarch Mining announces the second set of results from its 2021-2022 drilling program on its wholly-owned Swanson gold project, located 55 kilometres northeast of Val-d'Or, Quebec. The Swanson property comprises a contiguous group of 127 map-designated claims and one mining lease covering an area of 5,125.8 ha. "This drilling program on Swanson continues to return very wide mineralized zones, indicating that there is a lot of gold in the system and confirming our initial observations that the deposit, which remains open down-dip and down-plunge, could be significantly expanded," said Jean-Marc Lacoste, President and Chief Executive Officer of Monarch. "We are pleased with this second batch of assay results, which includes both significant widths and high-grade subintervals. We are confident that the ongoing drill program, which we have now increased to 13,000 metres, will continue to generate positive results."

09:16 EDT MSP Recovery says Eleventh Circuit overrules Southern District Court Judge - MSP Recovery announced that in an important new decision issued on Monday, the U.S. Circuit Court of Appeals for the Eleventh Circuit in MSP Recovery Claims, Series LLC, et al. v. Metropolitan General Insurance Company, et. al., Case No. 21-11547 overruled a Southern District Court Judge, finding that MSP Recovery properly alleged that Metropolitan General Insurance had a "demonstrated responsibility" to pay claims brought under the private cause of action provided for by the Medicare Secondary Payer Act. The statutory framework of the Medicare Secondary Payer Act recognizes that when liability insurers such as Metropolitan fail to pay for items or services under an automobile or liability insurance policy or under no-fault insurance, Medicare and Medicare Advantage Plans such as MSP Recovery's assignors are forced to make a conditional payment. When that happens, the primary plan must reimburse the secondary payer for these conditional payments "if it is demonstrated that such primary plan has or had a responsibility to make payment with respect to such item or service." See 42 U.S.C. Section 1395y(b)(2)(B)(ii). The law recognizes this mandate as the "demonstrated responsibility requirement." As set forth in the opinion, the Eleventh Circuit held that MSP Recovery's lawsuit properly alleged that Metropolitan had a "demonstrated responsibility" to pay the claims brought by MSP Recovery on behalf of various assignors under the private cause of action provided for by the Medicare Secondary Payer Act. In rendering its decision, the Eleventh Circuit relied on three preceding opinions that it issued in favor of MSP Recovery overturning twelve prior improper dismissals by Southern District of Florida judges. MSP Recovery believes that the decision rendered by the Eleventh Circuit in Metropolitan has broader implications because several other Southern District Court judges have dismissed, or partially dismissed, claims asserted by MSP Recovery in several other pending lawsuits that remain on file. MSP Recovery believes that this latest ruling from the Eleventh Circuit will likely impact the scope of the claims being litigated in those actions.

09:14 EDT Honest Company launches at Walmart to expand U.S. distribution - The Honest Company (HNST) announced that it has expanded distribution to Walmart (WMT). The brand is now available on Walmart.com and will launch in thousands of Walmart stores in the fall. The widespread distribution at Walmart will allow The Honest Company to expand its accessibility to existing and new consumers, providing a convenient shopping experience with additional ways to shop Honest favorites online and in-store. Through this launch, The Honest Company will expand its reach as a clean and sustainability-focused brand to the millions of customers who shop at Walmart each week. "Honest and Walmart are both committed to helping customers live better. This key addition to our strategic list of retailers not only enables us to increase distribution of our baby and personal care products, but also strengthens our ability to grow our community of conscious consumers," said Nick Vlahos, Chief Executive Officer of The Honest Company. "Our expansion to Walmart is the perfect example of our omni-channel retail strategy at work, enabling us to bring access to our products in stores and on the digital shelf to even more consumers every day."

09:13 EDT Skechers down 4% as short-seller Spruce Point sees 30%-50% downside risk - Spruce Point Capital Management, which focuses on forensic research and short-selling, issued a report entitled "A Skechy Investment" that outlines why the firm believes shares of Skechers face up to 30% to 50% downside risk to $18.60-$26.00 per share. Spruce Point believes that Skechers' revenue growth over the past five years has largely been the result of two transitory catalysts and it forecasts that the company will experience a "material" revenue growth slowdown. The firm believes Skechers is "just a moderate growth shoe company that will likely never be able to compete with the likes of Nike, Adidas or Puma," adding that given its belief that Skechers' growth rate will compress, its multiple will contract and its free cash flow generation will remain below average, "we find many reasons for Skechers to trade at a discount to its broader shoe peers." Reference Link

09:12 EDT Dine Brands plans to open five new IHOP restaurants in Saudi Arabia - Dine Brands International announces plans to open five new IHOP restaurants in the western Kingdom of Saudi Arabia , including Jeddah, Mecca, Medina, and cities along the Red Sea coast, with the first location scheduled to open in Jeddah in early 2023. The agreement with IHOP Franchisee Ahmed Marashde is a show of IHOP's continued expansion in the Middle East, further illustrated by the successful IHOP opening in Cairo, Egypt at the Cairo Festival City Mall and continued ghost kitchen expansion within the region.

09:11 EDT General Electric, BAE Systems announce technical collaboration - BAE Systems (BAESY) and General Electric (GE) announced a technical collaboration to explore next generation adaptive power management systems in the Combat Air domain. GE has delivered electrical power demonstration equipment into the BAE Systems lab to start exploring how to adopt and use solid state power controllers. Adaptive and dynamic power management systems, utilizing solid state power controllers, enables the use of software to implement, modify and control aircraft utility power functions. There are further opportunities for a continued collaboration beyond this demonstration activity, subject to the current active tender process.

09:09 EDT BASF confirms final phase of MDI expansion at Geismar Verbund site - BASF is moving forward with the final phase of the expansion project for the methylene diphenyl diisocyanate plant at its Verbund site in Geismar, Louisiana. With this third step of its multiphase capacity expansion, BASF will increase production capacity to 600,000 metric tons per year by the middle of the decade and support the ongoing growth of its North American MDI customers. The company kicked off the expansion project in 2018 with a staggered approach consisting of three investment phases. The investment in the final expansion phase from 2022 to 2025 amounts to $780 million. Leveraging state-of-the-art technology, the expansion will showcase the highest safety standards combined with advanced digitalization in its operations. BASF is now entering the final phase of the expansion, targeted for completion by the end of 2025. The first phase of the expansion project involving the construction of a new MDI synthesis unit was put in operation in October of 2020. The second phase, which started operations in 2021, expanded several existing upstream units. With the third and final expansion phase, which includes several new upstream units and a splitter, the new overall MDI output of the Geismar complex will increase to 600,000 metric tons.

09:08 EDT Sidus Space expands relationship with Teledyne Marine - Sidus Space (SIDU) announced its growing relationship with Teledyne Marine, a part of Teledyne (TDY), following a Q2. The three-month period marks the strongest revenue quarter between the parties since their partnership began four years ago. Sidus Space signed its first two-year master supply agreement, or MSA, with Teledyne Marine in July 2019, followed by a two-year product pricing agreement, or PPA, in September 2021. As part of the increasing scope of work and revenue with Teledyne Marine, Sidus Space will now manufacture components for Teledyne Marine's Massachusetts facility and will continue supplying components to Teledyne Marine's facilities in Texas and Florida.

09:07 EDT Allegro MicroSystems announces new distribution partnership with Mouser - Allegro MicroSystems announced that it has entered into a new distribution partnership with global semiconductor and electrical component distributor Mouser Electronics. Allegro products are now available for sale on the Mouser website, with new ones to be added as they become available. The partnership extends Allegro's global distribution footprint, and gives customers new options for purchasing product samples, evaluation boards, and production inventory. "This partnership greatly enhances our commitment to creating and supporting a vibrant and diverse customer base," said Max Glover, Senior Vice President of Sales at Allegro. "Mouser offers unmatched global logistics, giving engineers and designers access to our innovative ICs in a one-stop-shopping experience - leaving them more time to design and build new, exciting products."

09:06 EDT Blackstone, Hudson Pacific get approval to develop Sunset Waltham Cross Studios - Blackstone (BX) and Hudson Pacific (HPP) announced they have received a resolution at planning committee to develop Sunset Waltham Cross Studios, a new studio facility for feature films, television and digital production in Broxbourne, Hertfordshire. Preliminary site work is expected to start in the second half of 2022 with construction to commence in 2023 and the potential delivery of the project by year-end 2025. The project anticipates creating over 4,800 jobs in Broxbourne and the surrounding area and contributing more than GBP 300M annually to the local economy. Further expanding their partnership, funds managed by Blackstone and Hudson Pacific will transform a 91-acre site into a state-of-the-art, 1.2M square-foot studio campus, creating one of the UK's largest film and television production locations. The project will include 21 sound stages totaling 470,000 square feet, 420,000 square feet of workshop and mill space, and 250,000 square feet of stage-adjacent production office and support space as well as abundant amenity, basecamp and backlot spaces.

09:06 EDT Taboola signs new 1-year deal with Cox Media Group - Taboola announced a renewed one-year deal with Cox Media Group. This will be the 10th year that Taboola has provided audience recommendations to readers of Cox Media Group digital properties. In 2022, Cox Media Group began utilizing Taboola's Read More feature, which helps publishers engage mobile users before they bounce by raising the visibility of below-article units higher up on the page while enabling interested users to continue reading the full article. Since its implementation, Read More has delivered a 203 percent mobile ad revenue uplift for Cox Media Group. "As we hit the decade mark together, Cox Media Group has shown a willingness to adopt new Taboola innovations, insights and tech that contributed to their rapid growth. Local news continues to be critical, and the massive reach of Cox Media Group's local news network is especially important," said Adam Singolda, CEO at Taboola. "Their mission to inform, entertain and elevate diverse audiences and communities is remarkable. Playing a part in Cox Media Group's mission and continued growth, while also becoming their longest-standing partner in our space, is a testament to the mutual trust we've developed."

09:05 EDT Winnebago's Barletta announces 184,000 sq. ft. production expansion - Barletta Pontoon Boats, a subsidiary of Winnebago Industries and an innovative builder of high-quality marine products, announces that groundbreaking will occur later this summer on a new 184,000 square foot production facility located on their existing 37-acre campus in Bristol. Barletta's total footprint will expand to over 425,000 square feet or almost three times the size of its original facility in 2017. The expansion is planned to be available for production in the spring of 2023 and is expected to create more than 200 new jobs. "We established Barletta with the goal to redefine the pontoon segment with boats of unrivaled craftsmanship for boaters throughout North America. We have delivered on that objective in partnership with our dealers. This expansion exemplifies the continued progress we have achieved with the commitment and dedication of our team, and the support of Winnebago Industries," said Bill Fenech, President & Founder of Barletta Pontoon Boats. "Today and into the future, we will continue striving to deliver boats with unsurpassed quality." The current Barletta campus includes the original Plant 1 manufacturing facility which houses welding, fabrication, decking operations, and space dedicated to warehousing and offices. Plant 2 was completed in 2021 and houses assembly operations for the Company's Lusso, Corsa, and Cabrio pontoon boat lines. Both manufacturing facilities are currently nearing capacity, and this expansion adds future flexibility. An official ground-breaking ceremony will take place in late summer/early fall of 2022.

09:03 EDT Blink Charging selected as purchasing program vendor by FSA CPP - Blink Charging announced the successful contract award with the Florida Sheriffs Association, FSA, Cooperative Purchasing Program, CPP, as an official vendor for electric vehicle power stations. The CPP provides value to public procurement departments, allowing agencies to aggregate demand to procure EV hardware and services from pre-selected EV charging suppliers including Florida based Blink. As a CPP vendor, Blink products will be made widely available to CPP participants, providing them with direct access to Blink's EV charging solutions. As a preferred CPP vendor, Blink now has the potential to reach and contract with thousands of state and local agencies, municipalities, and educational organizations across Florida.

09:01 EDT Boeing, Aviation Capital Group announce order for twelve 737-8 jets - Boeing and Aviation Capital Group at the Farnborough International Airshow announced the aircraft lessor is growing its 737 MAX portfolio with an order for 12 additional 737-8 jets. As the travel market recovers, ACG is increasing its 737-8 offering to meet airline demand for modern, fuel-efficient, and sustainable operations.

09:00 EDT Lithium Americas publishes 2021 ESG-S Report - Lithium Americas published its 2021 Environment, Social, Governance and Safety Report. The Report themed Enabling Transition, reaffirms the Company's commitment to responsible development and production, as well as highlights the Company's ESG-S practices and overall progress made over the past two years. 2021 ESG-S REPORT HIGHLIGHTS: Achieved our target of zero harm, zero fatalities and zero recordable work-related injuries in 2020 and 2021. In 2021, we had zero percent employee turnover and increased gender diversity on our Board and executive leadership team. Thacker Pass is actively participating in the locally based Negotiating Work Group, which is dedicated to developing agreements to guide the construction and operation of Thacker Pass, with a focus on identifying solutions that protect the safety and well-being of community members. 52 training sessions in construction skills, heavy equipment operator and cultural monitoring for archeological mitigation work delivered to members of the Fort McDermitt Paiute and Shoshone Tribe. In Spring 2022, 11 Tribe members participated in their first monitoring activities. Thacker Pass received its Record of Decision from the US Bureau of Land Management following the completion of the National Environmental Policy Act process, as well as all key state environmental permits from the Nevada Division of Environmental Protection. In September 2021, Lithium Americas was approved as an IRMA Pending Member, which means that the Company commits to have Thacker Pass audited against the new draft IRMA Ready Standard for exploration and development within 12 months of its availability for application.

08:54 EDT Vicinity Motor enters distribution agreement with Schetky Bus and Van Sales - Vicinity Motor announced that it has signed a distribution agreement with Schetky Bus and Van Sales to offer the Vicinity Lightning, Vicinity Classic and VMC-Optimal vehicles, including an initial commitment for 18 vehicles. Schetky is headquartered in Portland, Oregon and has five full-service locations offering commercial buses, school buses, mobility vans, and passenger vans with customers ranging from assisted living communities, public transit agencies, school districts, casinos, churches, childcare facilities, medical transportation, and limousine companies. Under the terms of the agreement, Schetky will distribute Vicinity vehicles throughout Washington, Oregon, Idaho and Alaska. The Vicinity line adds to Schetky's portfolio of existing internal combustion and electric vehicles.

08:48 EDT Altamira Therapeutics announces publication on SemaPhore platform - Altamira Therapeutics announced the publication of a peer-reviewed article in the scientific journal Pharmaceutics titled, "The potential of cell-penetrating peptides for mRNA delivery to cancer cells," that covers an independently-funded study comparing various mRNA delivery platforms conducted by a Korean research group. The comparison included Altamira's SemaPhore platform, which is based on p5RHH, a cell-penetrating peptide. The study authors concluded, "Our results showed that amphipathic CPPs exhibited more effective uptake and transfection capacity than cationic CPPs. Notably, the p5RHH/mRNA complexes could be selected for potential cancer therapy." In their study, the authors compared in vitro eight different, well-known CPPs for their effectiveness in cellular uptake, transfection and expression of mRNA payloads in cancer cells. While mRNA payloads are currently delivered mostly via lipid-based nanoparticles, the authors highlight several important disadvantages of this technology including limited stability as well as LNP-related toxicity and immunogenicity. CPPs may help to address these challenges. Typically, they are cationic or amphipathic, enabling them to cross biological membranes. In the study, three cationic and five amphipathic CPPs were evaluated, the latter including Altamira's SemaPhore. The results demonstrated that the amphipathic CPPs yielded more effective cancer cell uptake than cationic peptides, together with better mRNA translation and fluorescent protein expression inside of cells. Within the group of amphipathic CPPs, SemaPhore-mRNA generated more efficient translation and protein expression than did the others.

08:44 EDT Nascent Biotech receives notice of allowance for issuance of additional patent - Nascent Biotech announced that the United States Patent and Trademark Office has issued a Notice of Allowance for claims related to the Company's lead candidate Pritumumab. The allowed patent application, which is titled, "KITS AND CONTAINERS FOR TREATING VIMENTIN EXPRESSING TUMORS" provides broad protection for Pritumumab and the storage conditions related to its use in clinical applications. A patent from the recently allowed application is pending issuance and is expected to be issued in the near future.

08:41 EDT Splash Beverage extends distribution in Arizona with 86 retail locations - Splash Beverage Group announced that it has extended the distribution of TapouT through agreements with three separate convenience store chains across Arizona. All four SKUs of TapouT Performance Drinks will now be available in CobbleStone AutoSpa locations, Carioca Convenience Stores and all of the 4-Sons Convenience Store locations. Cobblestone, Carioca Convenience Stores and 4 Sons Convenience Stores manage restaurants and fueling / service stations across Arizona. In total, TapouT will now be available in an addition 86 high-traffic locations. Robert Nistico, Splash Beverage Group's Chairman and CEO, commented, "These three agreements place TapouT in an additional 86 premium high-volume locations across Arizona and come directly out of our partnership with Kalil Bottling. This is the blocking and tackling, chain by chain, large and small that builds brands, having distribution partners who understand this and know how to execute is invaluable. Kalil is of course one of the top distribution companies in the entire western U.S., and their support and reputation were critical in helping us secure these agreements along with other high-end grocery chains already announced. We believe the "cold-bottle" availability will be a significant driver of consumer acceptance and growth for TapouT. TapouT is best consumed cold, and as consumers visit these convenience stores during their daily routines, they will often grab a cold drink and consume it immediately after purchase. This represents another successful branch of our retail strategy and we're grateful to Kalil for their support and we look forward to further growing our brands awareness with them."

08:41 EDT Stifel Financial appoints Ruben Roy as MD, equity research analyst - Stifel Financial announced the hiring of Ruben Roy as a Managing Director and Equity Research Analyst covering the Applied Technology sector. He is based in the firm's New York office. Roy brings more than 20 years of sell-side experience to Stifel, most recently with WestPark Capital, where he was a founding partner of the firm's institutional business.

08:39 EDT net2phone partners with UPSTACK - net2phone, subsidiary of IDT, announced a strategic partnership with UPSTACK. The partnership enables UPSTACK's extensive network of expert advisors to offer net2phone's cloud communication solutions to clients through UPSTACK's industry-transforming platform, trusted client relationships, and advanced technology. "Through this partnership, we will collaborate with UPSTACK's highly regarded technology experts and advisors...enabling their clients to leverage the power of the cloud for smarter conversations," said Jonah Fink, President of net2phone. "This agreement reflects net2phone's singular commitment to our channel partners' success through a comprehensive partners' program including industry-leading incentives, flexible pricing, and white-glove on-boarding."

08:39 EDT EXL, Oliver Wyman, Corridor Platforms team to launch risk decisioning solution - EXL, Corridor Platforms and Oliver Wyman announced a joint venture to develop a risk decisioning-as-a-service solution for financial institutions. The breakthrough new solution leverages advanced analytics, AI and the cloud to deliver instant credit decisions necessary to support digital lending initiatives such as point-of-sale financing, digital loans, mortgage approvals and real-time credit limit changes. The rapid-fire growth of digital lending has put mid-sized and regional banks at a significant disadvantage versus national players with the tech infrastructure in place to support real-time decisioning. With this new decisioning-as-a-service solution, banks and credit unions of every type will now be able to take advantage of a hosted advanced decisioning cloud populated with external and internal data sources and a dedicated team of industry experts, while maintaining full control of compliance and governance. This will enable them to become competitive immediately versus the most advanced lenders.

08:37 EDT Milestone names Hager & Werken exclusive STA distributor in Germany, Austria - Milestone Scientific announced it has entered into a distribution agreement granting Hager & Werken exclusive distribution rights to market Milestone's STA Single Tooth Anesthesia System, STA, in Germany and Austria. The STA system enables painless anesthesia through precise, digitized and computer-controlled dosing. The STA system offers significant benefits to both patients and clinicians through painless injections, shorter wait times for anesthesia, fewer complications, and reduced patient cancellations. "We are happy to take on this engagement with great enthusiasm and will do our utmost to elevate this exciting technology in Germany and Austria," said Patrick Hager, managing partner of Hager & Werken. "We see the ability to anesthetize individual teeth, precisely controlling flow rate, and to do so without pain or side-effects, represents a significant advancement in dentistry, and we look forward to our further cooperation."

08:36 EDT Novavax announces expanded agreement with SK bioscience for Covid-19 vaccine - Novavax announced that it has signed agreements with its partner, SK bioscience, for the manufacturing and supply of a version of the Novavax COVID-19 vaccine containing omicron variant and for the manufacture of the vaccine in prefilled syringes. The companies signed an agreement for the technology transfer of Novavax' proprietary COVID-19 variant antigen materials so that SK bioscience can manufacture the drug substance targeting COVID-19 variants including the Omicron BA.5 subvariant. "Non-clinical data generated to date demonstrate that our COVID-19 vaccine offers broad immune responses including against circulating variants, such as Omicron BA.5," said Stanley C. Erck, President and CEO, Novavax. "We are accelerating our clinical program evaluating an Omicron BA.5 component to our vaccine and look forward to continuing to work with SK bioscience as an important manufacturing partner." In addition, the companies have signed an agreement to manufacture and supply the Novavax COVID-19 vaccine in a prefilled syringe. SK bioscience will begin work to enable the manufacturing process for commercial supply of the vaccine in prefilled syringes in 2023.

08:35 EDT PharmaCyte Biotech reports interim results in malignant ascites mouse study - PharmaCyte Biotech announced that it has achieved positive interim results in its study to establish a malignant ascites mouse model which will form the basis for further testing of the effectiveness of its CypsCaps plus ifosfamide pancreatic cancer therapy for the treatment of malignant ascites. The study is being conducted by Heidelberg Pharma, a leading German biotechnology company focused on cancer therapies, using colon carcinoma cells from a Master Cell Bank established by Austrianova implanted in genetically susceptible mice. Primary objectives include establishing parameters with respect to optimum tumor cell inoculation dose; timing curve with respect to tumor growth; and the most accurate method to assess tumor burden. The last point is particularly important because it provides a gauge to measure the effectiveness of therapeutic interventions. Initial data in the study indicate that a measure of overall tumor volume is likely a more accurate way of tracking tumor burden when compared to measuring labeled tumor cell fluorescence. Tumor volume in the study is being reported using an adaptation of the Sugarbaker-index. The Sugarbaker-index is a widely used and accepted quantitative prognostic indicator for patients with malignant ascites. PharmaCyte's Chief Executive Officer, Kenneth L. Waggoner, said, "We are highly encouraged that Heidelberg Pharma's work with this study to establish a malignant ascites mouse model is proceeding exactly as we had hoped and that it has yielded valuable information as we work diligently to advance our therapy for malignant ascites. We are confident that all our objectives in this study will be achieved. We will continue to keep our shareholders informed as work progresses at Heidelberg Pharma." Malignant ascites is caused by an accumulation of fluid in the peritoneum causing the abdomen to swell as a result of cancer. It is often associated with ovarian, uterine, cervical, colorectal, stomach, pancreatic, breast and liver cancers. Malignant ascites can result in significant impairment to the quality of life of a cancer patient and reduce survival. Currently, available treatments are mainly supportive and palliative. In most patients, development of malignant ascites is a sign of advanced disease and poor prognosis. PharmaCyte expects its treatment to offer cancer patients a therapy that slows down or eliminates the production and accumulation of malignant ascites fluid. There is currently no such treatment on the market.

08:35 EDT Scynexis presents data from Phase 3 CANDLE nested sub-study - SCYNEXIS announced the presentation of positive outcomes from the CANDLE 304s nested sub-study investigating oral ibrexafungerp in patients with recurrent vulvovaginal candidiasis, RVVC, who failed fluconazole treatment. The results were presented during the International Society for the Study of Vulvovaginal Diseases, ISSVD, XXVI World Congress and International Vulvovaginal Disease Update 2022 held in Dublin, Ireland, July 15-20, 2022. "We are thrilled to present these data demonstrating positive outcomes in RVVC patients who failed fluconazole therapy for an acute VVC episode," said Nkechi Azie, M.D., Vice President, Clinical Development and Medical Affairs at SCYNEXIS. "The response to ibrexafungerp in this clinically challenging population is extremely encouraging and further demonstrates the potential efficacy of ibrexafungerp to treat recurrent yeast infections in patients with limited treatment options. We hope to expand upon these data with the recently announced Phase 3b VANQUISH study." The CANDLE open-label sub-study enrolled 24 patients who failed to respond to an initial three-doses of fluconazole given over seven days. Fluconazole failure was defined as persistent vaginal signs and symptoms score equal to or greater than three after therapy. Participants received a one-day treatment of ibrexafungerp. In this population, 71% of patients achieved a significant reduction or elimination of signs and symptoms after treatment with ibrexafungerp. This positive trend was also confirmed in the subset of subjects who in addition to having a clinical failure also had persistent positive cultures after fluconazole treatment. Favorable clinical response after a single day of ibrexafungerp was reported in eight of 10 subjects in this sub-group. SCYNEXIS plans to present CANDLE main results next month during the Infectious Diseases Society for Obstetrics and Gynecology Annual Meeting being held in Boston, August 4-6, 2022.

08:34 EDT Truist Financial targeting positive operating leverage for FY22 - Continues to target positive operating leverage for full year 2022. The bank's Board will consider a resolution to increase common dividend 8% to 52c per share in 3Q22, it said. It is targeting ROATCE in the low 20s and ER in the low 50cs. Comments taken from Q2 earnings conference call presentation slides.

08:33 EDT Edible Garden to distribute products in 28 Food Bazaar locations - Edible Garden announced it has begun distributing products in 28 of Food Bazaar's retail locations.

08:32 EDT Denham Capital provides DSI sustainability bond to South Jersey Industries - Denham Sustainable Infrastructure announces it has committed to a corporate private bond investment through its Sustainable Infrastructure Credit platform, as part of South Jersey Industries' latest private placement financing. On July 14, 2022, SJI entered a Note Purchase Agreement, arranged by KeyBanc Capital Markets and PNC, providing for the issuance in a private placement of $400 million aggregate principal amount of senior unsecured fixed rate notes in four series. One of those series consists of notes in an aggregate principal amount of $80 million, whose net proceeds are required to be used for sustainable projects under a self-certification framework using Key Performance Indicators and parameters aligned with Denham Sustainable Infrastructure Credit. Of such amount, $200 million, including $40 million of Green Bonds, were issued on July 14, 2022. The remaining 200 million of notes, including $40 million of Green Bonds, are expected to be issued on September 15, 2022.

08:32 EDT Verizon awarded over $400M modernization contract with FBI - Verizon Public Sector announced an over $400M Enterprise Infrastructure Solutions, EIS, task order with the Federal Bureau of Investigation, FBI, to help the agency meet increasing demands for data bandwidth around the globe successfully. "We understand the critical nature of the work we will do with the FBI to improve network availability, enhance operational efficiency, use tailored approaches to meet individual division needs, and help modernize technology," said Maggie Hallbach, Senior Vice President, Public Sector at Verizon. "Building on nearly 20 years of partnership with the Bureau, this next phase will provide stable solutions and a modern network that is faster, more scalable and secure that will help the FBI achieve its mission."

08:31 EDT Lazydays names John North as new CEO, effective September 6 - Lazydays Holdings has appointed John North as CEO and a member of the Board of Directors, effective September 6, 2022. "It is an honor to welcome John North to Lazydays," said Chris Shackelton, Chairman of the Board. "John is an accomplished executive with an admirable track record of driving success across multiple companies. We could not be more excited about the combination of John's operational strengths, paired with a disciplined growth orientation. John brings a deep understanding for building durable scale in multi-unit, high ASP dealership models, with superb judgement in allocating capital through business cycles. This combination is highly relevant for Lazydays, as the Company assesses a widening range of compelling investment opportunities to drive shareholder value. Furthermore, as a leader of large public companies, John has a stellar reputation and history of developing strong relationships with investors and capital sources. Importantly, John is a collaborative leader whose skillset will complement and amplify the talented Lazydays team."

08:28 EDT HP Inc. announces early participation results of exchange offer - HP Inc. (HPQ) announced that it has received the requisite consents to adopt certain proposed amendments with respect to all outstanding notes of Plantronics, Inc. (POLY). The results are based on early tenders in the offer to exchange any and all outstanding Poly Notes for up to $500,000,000 aggregate principal amount of new notes to be issued by the Company and the related solicitation of consents to adopt the Amendments to the indenture governing the Poly Notes, commenced by HP on June 27, 2022. The Company has also extended the deadline for the Early Participation Premium from 5:00 p.m., New York City Time, on July 18, 2022 to the Expiration Date. Capitalized terms used but not defined in this press release shall have the meanings ascribed to them in the Offering Memorandum and Consent Solicitation Statement. As of 5:00 p.m., New York City time, on July 18, 2022, $490,506,000 in aggregate principal amount of Poly Notes had been validly tendered and not validly withdrawn. For each $1,000 principal amount of Poly Notes validly tendered and not validly withdrawn at or prior to the Early Participation Date, eligible holders of Poly Notes will be eligible to receive $1,000 principal amount of HP Notes, plus a consent payment, such that the aggregate Consent Payment will be $8,000,000, to be shared by all such consenting holders. Based on the aggregate principal amount of Poly Notes validly tendered and not validly withdrawn at or prior to the Early Participation Date, the Consent Payment will be approximately $16.31 for each $1,000 principal amount of Poly Notes. The Total Consideration includes the Early Participation Premium, payable in principal amount of HP Notes, of $30. HP is also hereby amending the terms of the Exchange Offer so that, for each $1,000 principal amount of Poly Notes validly tendered and not validly withdrawn after the Early Participation Date but prior to the Expiration Date, eligible holders of Poly Notes will now be eligible to receive $1,000 principal amount of HP Notes, which includes the Early Participation Premium. To be eligible to receive the Exchange Consideration, eligible holders must validly tender their Poly Notes at or prior to the Expiration Date.

08:21 EDT Connexa Sports appoints Krishnan to board of directors - Connexa Sports Technologies announces the appointment of Rohit Krishnan to its Board of Directors. Krishnan is currently a Venture Capitalist at Unbound,. "We are thrilled to welcome Rohit to our Board and feel that his unique experience as both an operator and investor across various technology industries will serve us well as we execute on our connected sports technology strategy," said Connexa Sports CEO Mike Ballardie.

08:19 EDT Integra LifeSciences appoints Lo as Director - Integra LifeSciences Holdings (IART) announced the appointment of Renee Lo to its board of directors as an independent director to fill an existing vacancy, effective July 18, 2022. Lo currently serves as a general manager for Microsoft (MSFT), leading its data and artificial intelligence business in Asia. She is responsible for helping strategic customers of Microsoft reshape their business models through digital technologies.

08:18 EDT Duolingo partners with HBO Max ahead of 'House of the Dragon' premiere - Duolingo (DUOL) announced its official partnership with HBO Max (WBD) for HBO Original "House of the Dragon." The "Game of Thrones" prequel premieres August 21 on HBO Max and to help fans prepare, Duolingo is launching an updated High Valyrian course, the fictional language spoken in the show, including over 150 new words and more than 700 new sentences. To promote the updated course, Duolingo is rolling out an integrated marketing campaign teasing new phrases on cryptic billboards in major cities across the country, including an iconic space in Times Square.

08:16 EDT AerCap announces order for five additional Boeing 787-9 Dreamliners - AerCap Holdings (AER) announced an order for five additional Boeing (BA) 787-9 Dreamliners. The announcement was made at the Farnborough International Airshow. This transaction brings AerCap's orders for the 787 aircraft to 125, owned and on order.

08:14 EDT HP Inc. introduces HP LaserJet Managed E800/E700 series - HP Inc. introduced the HP LaserJet Managed E800/E700 series, a new portfolio of multi-function printers that support and inspire a productivity-focused hybrid workforce, with intelligent solutions that can make work flow faster.

08:11 EDT Catalyst Biosciences sends letter to stockholders - Catalyst Biosciences announced that it mailed a letter to its stockholders in connection with the Company's upcoming 2022 Annual Meeting of Stockholders, scheduled to be held on August 15, 2022. Catalyst's Board of Directors, following extensive engagement with the Company's largest stockholders, developed a plan to return all of the Company's available cash expeditiously to stockholders, after reserving for liabilities and obligations. "We estimate that we will ultimately be able to provide stockholders with as much as $65 million in cash, in one or more distributions, and we continue to pursue the monetization of our remaining assets and are hopeful we can generate additional cash to distribute," the company said. "Regrettably, a stockholder, JDS1, who has a history of gaining control, or trying to gain control of, cash-rich companies for its own benefit, is impeding the Cash Distribution Plan. JDS1 is seeking to replace three Catalyst directors at this year's Annual Meeting with three of its close associates who have longstanding connections to Julian Singer, JDS1's principal, and his family. Two of those three JDS1 candidates are CEOs of public companies that have signed management contracts with JDS1 and pay JDS1 substantial fees to manage their assets and cash. If it is successful at this year's Annual Meeting, JDS1 will have influenced the appointment of four of Catalyst's seven independent directors - a majority of the Company's independent board members," the company added. Catalyst urges stockholders to support the Cash Distribution Plan by reelecting the Company's nominees, by voting "FOR" ALL nominees on the WHITE proxy card

08:10 EDT PetVivo forms nonprofit PetVivo Cares - PetVivo Holdings announced the launch of a philanthropic endeavor called PetVivo Cares, a registered 501(c)(3) organization. PetVivo Cares is partnering with the animal healthcare community to advance the health and well-being of animals experiencing discomfort from lameness or other joint related afflictions, such as osteoarthritis. PetVivo and PetVivo Cares have a genuine passion for animals. To demonstrate this passion, PetVivo has set a goal to donate 500 no-cost Spryng injections to animal organizations. Spryng, an injectable veterinary medical device administered by licensed veterinarians, will be provided on a financial or critical needs basis. With the support of private donations, PetVivo Cares can grow the success stories exponentially, expanding the PetVivo's reach to treat even more dogs, cats, horses and other animals suffering from lameness and other joint related afflictions. Leading PetVivo Cares as Executive Director is Scott Herold, multi-award-winning philanthropist, youth advocate, and nonprofit record label executive.

08:08 EDT Lockheed Martin sees FY22 Aeronautics sales $26.75B, MFC sales $11.2B - Sees FY22 RMS sales $16.15B, Space sales $11.15B. The company previously forecast FY Aero sales $27.3B, MFC sales $11.3B, RMS sales $16.25B, Space sales $11.15B. Now sees Aero segment operating profit $2.87B, MFC $1.615B, RMS $1.66B, and Space $1.03B.

08:07 EDT Pulse8 gets NCQA Measure Certification for HEDIS MY2022 for Qualit8 - "Pulse8 is thrilled to announce that Qualit8, a Veradigm Network Solution, has achieved MY2022 Measure Certification from the National Committee for Quality Assurance, NCQA, for the third consecutive year. Veradigm is a leading provider of healthcare data, analytics and technology solutions and a business unit of Allscripts Healthcare Solutions . By earning NCQA Measure Certification, the industry's most rigorous assessment, Qualit8 demonstrates a commitment to delivering value and administrative efficiency to health plan customers..."This certification is a prime example of how Veradigm continues to deliver industry-leading, transparent analytics to our health plan customers," says President and Chief Commercial Officer Tom Langan. "As a Veradigm Network solution, Qualit8's NCQA-Certified HEDIS Measurement and Reporting Software provides health plans with a higher level of value by helping reduce healthcare spending, waste and improving administrative efficiency."

08:07 EDT Cognition Therapeutics to present analyses from ongoing trial of CT1812 - Cognition Therapeutics will be in attendance at the 2022 Alzheimer's Association International Conference being held in San Diego, CA from July 31 to August 4, 2022. Cognition's vice president of research, Mary Hamby, Ph.D. will present new proteomic analyses of disease biomarkers demonstrating the impact of CT1812 on disease processes in participants from the SPARC clinical study in mild-to-moderate Alzheimer's disease. CT1812 is an oral, small molecule that selectively binds to the sigma-2 receptor complex. Evidence implicates -2 receptors in the regulation of key cellular processes that are damaged in Alzheimer's disease, dementia with Lewy bodies and other neurodegenerative disorders. For the first time at AAIC, Cognition is hosting a scientific exhibit booth where clinicians and researchers can learn more about the company's clinical research initiatives. Cognition's ongoing clinical studies: DLB: the company recently announced that it dosed the first individual in its Phase 2 SHIMMER clinical study; Mild-to-moderate Alzheimer's disease: SHINE and SEQUEL are expected to yield top-line results in early 2023; Early Alzheimer's disease: In partnership with the Alzheimer's Clinical Trials Consortium, the START study is expected to commence dosing by end of year. Cognition's clinical programs, including the above four studies, are supported by grant funding exceeding $168 million awarded by the National Institute of Aging.

08:06 EDT AB Value-Radoff group issues statement on Rocky Mountain Chocolate board - AB Value Management and Bradley Radoff, who own approximately 17.6% of the outstanding shares of Rocky Mountain Chocolate Factory, issued the following statement in connection with their campaign to elect two highly qualified and independent candidates - Mary Bradley and Correne Loeffler - to the company's board of directors at the 2022 annual meeting of stockholders scheduled for August 18: "We believe Rocky Mountain continues to be held back by dysfunctional corporate governance and insufficient boardroom diversity. Unfortunately for stockholders expecting greater competence and stewardship from new leadership, the Company has merely shifted from operating under the value-destructive regime of a failed founder to the unstable regime of Chair Jeffrey Geygan. The best evidence of this appears to be the independent directors' poorly-communicated decisions to appoint, remove and then re-appoint Mr. Geygan as Chair over the past year. It is obvious to us that Mr. Geygan, who seemingly orchestrated the selection of his long-time associate, Robert Sarlls, as Chief Executive Officer and previously sought control of the Company, is prioritizing a self-serving agenda. We also question how Mr. Geygan has sufficient time to serve as Chair of Rocky Mountain when he is already Chief Executive Officer of Global Value Investment Corporation, which has four business lines, and Chairman of Nasdaq-listed Wayside Technology Group. Perhaps this is why he has not directly engaged with us since inappropriately seeking our vote solely for his election at last year's annual meeting in violation of his cooperation agreement with the Company or why the Company failed to resolve open litigations over the last 12 months. It seems the independent directors recognize Mr. Geygan is unqualified to lead them, but they lack the conviction required to appoint a more experienced and viable permanent Chair. We hope this failure to act is not the result of all directors having received an increase in compensation following Mr. Geygan's initial appointment as Chair. We also believe Brett Seabert is a conflicted and problematic director. We suspect Mr. Seabert is only on the Board because the Company's prior Chief Executive Officer was his long-time friend and best man. Mr. Seabert has no discernible experience in corporate governance, consumer brands or franchising. His irrelevant background includes serving as the Chief Financial Officer of a small private construction business and is almost entirely concentrated in the real estate development and construction sectors. After five years of service, it has become evident that he adds no detectable value to the Board and lacks strong alignment with stockholders based on his meager holdings. Lastly, we contend Mark Riegel is ill-suited to serve as Chair of the Nominating and Corporate Governance Committee. While Mr. Riegel has additive marketing and manufacturing experience, his lack of a public company background makes his selection as Chair of the Nominating and Corporate Governance Committee particularly perplexing. Under his watch, the Board has failed to add individuals with necessary franchise experience. The Board has also recently suffered the resignation of Elisabeth Charles, who was appointed Chair after we initially conveyed concerns regarding Mr. Geygan. It seems Mr. Riegel has done little to find a suitable replacement for Ms. Charles or enhance gender diversity in the boardroom. Most recently, the Board demonstrated its further disregard for stockholder-friendly governance by accelerating this year's Annual Meeting date in an apparent attempt to avoid having to use a universal proxy card. In addition, the Board has refused to agree to our settlement offer to appoint one female franchise expert to the Board in exchange for a multi-year agreement. It should be abundantly clear at this point that Rocky Mountain needs both of our candidates in the boardroom to foster proper corporate governance and unlock value for all stockholders."

08:05 EDT Skyharbour closes option to acquire initial 51% of Russell Lake project - Skyharbour Resources announces the closing of the previously reported Option Agreement with Rio Tinto Exploration Canada, a wholly owned subsidiary of Rio Tinto Limited, to acquire up to 100% of the Russell Lake Uranium Project, which comprises 26 claims covering 73,294 hectares of prospective exploration ground strategically situated between the Company's Moore Uranium project and Denison Mines' Wheeler River project in the eastern portion of the Athabasca Basin. The Project is a premier, advanced-stage exploration property given its large size, proximity to critical regional infrastructure, and the significant amount of historical exploration carried out on the property, which has identified numerous prospective target areas and several high-grade uranium showings as well as drill hole intercepts. The Property is centrally located between Cameco Corp.'s Key Lake mill to the south and McArthur River mine to the north. Access to the Property is via Highway 914, which services the McArthur River Mine and runs through the western extent of Property along with a high-voltage powerline that energizes the existing mining operations in the eastern portion of the Athabasca Basin. Skyharbour has filed an NI 43-101 Technical Report on the Russell Lake property written by Michelle McKeough, P.Geo., of TerraLogic Exploration Inc. The Technical Report is the culmination of previously reported and compiled historical data and geological reports and was commissioned in preparation for an upcoming drill program Skyharbour plans to carry out on the project. It provides a detailed description of the project including the historical exploration and drill results previously reported, as well as recommendations for future exploration programs. Under the terms of the Option Agreement, which now has TSX Venture Exchange approval, Skyharbour may acquire up to a 100% interest in the Russell Lake Uranium Project and will become operator of the Project during the earn-in period and afterwards if a joint venture is formed. An initial majority 51% interest in the Property may be earned by paying CAD $508,200, which has been paid, and issuing 3,584,014 common shares of Skyharbour, which has been issued, to RTEC. Skyharbour must also fund CAD $5,717,250 in exploration expenditures, inclusive of a 10% management fee to Skyharbour, over a period of three years, of which a total of CAD $1,905,750 must be spent within eighteen months. Skyharbour at this point can elect to enter into a 51% / 49% joint venture with RTEC subject to a standard dilution clause, or the Company can earn additional interest in the project. Skyharbour may then acquire an additional 19% to earn a total of a 70% interest in the Property by paying CAD $1,588,125 in cash or by issuing 2,226,096 shares. Additionally, Skyharbour must fund CAD $6,352,500 in exploration expenditures, inclusive of a 10% management fee to Skyharbour, over a period of the following two years. Upon Skyharbour earning a 70% interest, the Company may elect to continue on a 70% / 30% joint venture basis, subject to a standard dilution clause, or it may acquire the remaining 30%, if RTEC elects not to contribute, for a total undivided interest of 100% of the Property by paying CAD $33,033,000 in cash or by issuing 42,598,565 shares or a combination thereof to prevent RTEC from owning over 19.9% of Skyharbour. Upon Skyharbour's 100% acquisition, the Property will become subject to a 1% NSR Royalty payable to RTEC. The royalty may be reduced to 0.5% by payment of USD $750,000 to RTEC. The claims comprising the Property are subject to various existing underlying royalties to other parties. All securities issued in connection with the Option will be subject to a hold period ending four months and one day after issuance.

08:04 EDT Inovio to reduce full-time workforce by 18%, contractors by 86% - INOVIO announced that it has implemented a corporate reorganization designed to extend its cash runway and to focus on key clinical programs with the goal to drive long-term growth. The reorganization, which includes an 18% workforce reduction in full-time employees and 86% reduction in contractors, along with other cost-saving measures, is expected to reduce operating expenses by approximately 30% over the next 18 months and will extend the Company's cash runway into the third quarter of 2024. These projections do not include any funds that may or may not be raised during the time period through the Company's existing ATM or other fundraising mechanisms. INOVIO expects a one-time restructuring charge of approximately $1.6 million in the third quarter of 2022. "The organizational adjustments we've announced today underpin our strategy to realize the promise of DNA medicines and better position INOVIO for future growth," said Dr. Jacqueline Shea, CEO. "By driving operational efficiencies throughout our organization, we are focused on advancing our lead pipeline candidates toward commercialization and optimizing our chances of success." INOVIO expects to have data readouts from key studies that will further inform the strategic development of these leading DNA medicine assets later this year.

08:04 EDT Humacyte announces presentation of preclinical data on HAV - Humacyte announced that six-month outcomes from a preclinical study of a small diameter Human Acellular Vessel in coronary artery bypass grafting will be presented at the Basic Cardiovascular Sciences Scientific Sessions taking place in Chicago, IL July 25-28, 2022. Title: "Tissue-engineered Human Acellular Blood Vessels for Coronary Artery Bypass Grafting."

08:03 EDT Allena announces completion of enrollment of cohorts A, B of ALLN-346 - Allena Pharmaceuticals reported completion of enrollment of the first two cohorts of its ALLN-346 Phase 2a Study 202 in gout patients with stage 2 and stage 3 chronic kidney disease, CKD. ALLN-346 is a bio-engineered enzyme specifically designed to degrade urate in the gastrointestinal tract without systemic absorption and thereby reduce systemic urate levels in patients with hyperuricemia, gout and CKD. Cohort A has enrolled seven patients with an estimated glomerular filtration rate and Cohort B has enrolled twelve patients with an eGFR. David Clark, M.D., M.R.C.P., Chief Medical Officer of Allena Pharmaceuticals, Inc., stated, "We are pleased with the progress of our ALLN-346 Phase 2a program, and thank our patients, investigators and business partners for helping us achieve this operational milestone. This is an important step in our efforts to develop a new treatment option for patients with hyperuricemia, gout and advanced CKD. There is an established pathophysiologic adaptation of increased intestinal elimination of uric acid in patients with impaired kidney function, so we believe the ALLN-346 therapeutic strategy of degrading uric acid in the GI tract is based on a strong scientific rationale. We have been encouraged by initial data from Study 201, which have provided evidence supporting the GI mechanism of action for ALLN-346, including the positive correlation between serum uric acid reduction and the degree of renal impairment. We look forward to reporting additional topline safety and efficacy data from the cohorts thus far enrolled in the ALLN-346 Phase 2a development program later this quarter."

08:03 EDT Flowserve opens new Learning Resource Center - Flowserve announced the opening of a new Learning Resource Center, or LRC, on the Lamar University campus in Beaumont, Texas. The new LRC will provide Flowserve customers and Lamar University students with the opportunity to engage with Flowserve's innovative products and technology through hands-on, lab-based learning experiences.

08:02 EDT Keurig Dr Pepper names Andrew Archambault as president, Commercial - Andrew Archambault, who currently serves as Chief Customer Officer, has been promoted to the President, Commercial role, effective Aug. 1, and will become a member of the Executive Leadership Team, reporting to Dokmecioglu. Archambault joined KDP in 2018 and has more than 25 years of leadership experience in the CPG industry. In his new position, Archambault will continue to lead sales planning and execution for national and regional accounts, with the additional responsibility for fountain foodservice and revenue growth management. Mauricio Leyva, who joined KDP in 2020 and currently serves as President, Coffee, will assume an expanded role as Group President, effective Aug. 1. In this role, Leyva will continue to lead Coffee and add responsibility for the international businesses previously led by Dokmecioglu, as well as the continued evolution of the digitalization of KDP. David Thomas, who has been with KDP and its predecessor companies since 2006 and currently serves as Chief Research & Development Officer, will be retiring from the Company upon the naming of his successor. An external search is underway, and Thomas has agreed to remain with KDP to ensure a seamless transition.

08:01 EDT Keurig Dr Pepper announces executive leadership team changes

07:51 EDT Hire Technologies announces payment of debenture interest in equity - HIRE Technologies announces that it has elected to satisfy its obligation to pay $73,620 in interest as of June 30, 2022 to the holders of its 9% unsecured debentures issued August 21 and 24, 2020 by issuing 717,536 common shares of the Company. The common shares will be issued at a deemed price of $0.1026 per share in full satisfaction of the June 30th interest payment obligation in accordance with the terms of the Debentures. The shares for debt application remains subject to approval by the TSX Venture Exchange.

07:47 EDT Trailbreaker receives approval for Eagle Lake property acquisition - Trailbreaker Resources announced that acquisition of the Eagle Lake property has now been approved by the TSX Venture Exchange. In May, 2022 Trailbreaker announced the acquisition of their 100%-owned Eagle Lake property in south-central BC, Subject to approval. The Eagle Lake property covers 18,990 hectares of prospective ground directly adjacent to Consolidated Woodjam Copper Corp.'s Woodjam copper-gold porphyry project. In addition to staking, acquisition of the property involved the sale of claims held by Teck Resources to Trailbreaker. The sale was subject to the following terms: Trailbreaker shall issue 125,000 common shares within 7 business days of receipt of TSX Venture Exchange approval. Concurrent with the share issuance, Teck will transfer the title of the Property to Trailbreaker; Teck shall retain a 1% NSR on the Property.

07:36 EDT Lockheed Martin reports Q2 cash from operations of $1.3B; free cash flow $1B

07:33 EDT Lockheed Martin CEO says Q2 revenue 'affected by supply chain impacts' - "Lockheed Martin continued to deliver strong and consistent cash generation, returning over $1 billion in cash to shareholders in the second quarter through our industry leading dividend and our ongoing share repurchase program," said Lockheed Martin Chairman, President and CEO James Taiclet. "Although revenue in the period was affected by supply chain impacts and the timing of customer contract negotiations, our cost management initiatives resulted in margin expansion. Moreover, our robust cash generation also continues to provide the resources to invest in building the foundation for future revenue and margin growth opportunities through our classified program capex projects, hypersonics development efforts, and our 21st Century Security and internal Digital Transformation initiatives."

07:31 EDT Vasta Platform announces closing of investment in Educbank - Vasta Platform announces the completion, by its wholly-owned subsidiary, Somos Sistemas de Ensino S.A., of the minority investment in Educbank Gestao de Pagamentos Educacionais S.A. Vasta investment will total R$158M, for a 47.4% stake in Educbank, to be paid in: cash installments totaling R$88M, according to the growth of students served by Educbank and other conditions, and upon capitalization of credits arising from the sale of intangible assets by Somos, R$ 70M. Vasta will have the right to appoint two members (out of six) to the board of directors of Educbank.

07:16 EDT Power Nickel, Critical Elements Lithium release initial MRE on Nisk project - Power Nickel and Critical Elements Lithium Corporation are pleased to release the initial NI 43-101 compliant Mineral Resource Estimate on their "Nisk" Nickel Sulphide project near James Bay, Quebec. Power Nickel completed the acquisition of its option to acquire up to 80% of the Nisk Project from Critical Elements Lithium. The Nisk Project comprises a large land position with numerous high-grade Nickel intercepts. Since completion of the option, Power Nickel retained 3DGeo Solution Inc to create a geological model of the Nisk Project and used this as a guide to the very successful initial Power Nickel 2400-metre drill program completed last December and reported in March of 2022. On the basis of this drill program and the historical drill results, 3DGeo Solution Inc was mandated to produce a NI 43-101 compliant Mineral Resource Estimate and Technical Report. Engineering work related to defining a constraining pit shell and underground mineable shapes was contracted to InnovExplo Inc.

07:11 EDT React Gaming provides performance update on Parabellum esports team - React Gaming Group is pleased to provide an update on its wholly-owned Parabellum Esports subsidiary, acquired last February. Parabellum's men's esports team plays in the Rainbow 6 North American League run by Ubisoft. This men's esports professional league is composed of 10 teams and has three stages where teams each play one game against the other nine teams, with playoffs for the top four teams at the end of each stage. At the end of the season, the four best overall teams from the three stages compete in the world playoffs. Last year the prize money for the world playoffs was $3M. In its first year as a professional team, Parabellum has progressed very well and currently ranks in 6th place as of stage 2, when the team was joined by Alexandre "Blaz" Thomas, a top-10 European player and import from France, and Shaun "Gunnar" Pottorff, an 18-year-old rookie on the top-wanted list for some of the top contenders in the North American League. These new additions already proved their worth in stage 2 in a very competitive league, where the point spread between the first and sixth place was a mere two points. Stage 3 holds a lot of promise for this young team. Parabellum's women's team, which is based in Brazil, has also shown strong results, finishing in the top 4 in the Brazilian tournament "Ela Faz o Game". The team is playing in the "Circuito Feminino 2022" league and is currently in the stage 4 playoffs. These performances have enabled Parabellum Esports to attract its first paid sponsorship, with Shakepay, a Canadian technology company, as their first entry into esports.

07:09 EDT SpringBig reports 18% increase in texts sent on Independence Day - springbig highlighted data recorded during the weekends of July 4 and July 10. On Independence Day, the Company recorded an 18% increase in texts sent and a 22% increase in total campaigns distributed. Additional data obtained by springbig also highlighted an increase in overall sales, reward redemptions and visits. The Company's partners continued to flourish on 7/10 Oil Day. Campaigns, messages and credits increased by an average of 20% on July 9 and 50% on July 10 compared to each of the four previous Saturdays and Sundays, respectively. On July 9 and 10, 3.3 million messages were sent, using over 15 million credits. The widespread increase in campaigns, messages and credits used on July 10 resulted in a 15% increase in sales compared to each of the four previous Sundays. Arizona, California and Michigan enjoyed the most success with sales bumps of 20% or more on 7/10 Oil Day. The higher sales recorded on 7/10 Oil Day were generated by a 46% and 22% sales increase in concentrates and vaporizers, respectively.

07:07 EDT XPO named official transport partner for Tour de France Femmes avec Zwift - XPO Logistics has been selected by the Tour de France as the official transport partner for the 2022 women's competition, to be held July 24-31. The eight-stage race will be the first edition of the Tour de France Femmes avec Zwift. XPO will use 14 drivers to transport 200 tons of cargo along the route, traveling over 1,000 kilometers by truck. The company is also supporting the Tour de France currently underway, with 58 drivers moving 570 tons of cargo over 3,328 kilometers. Luis Gomez, president of XPO Logistics - Europe, said, "We're delighted to expand the scope of our 42-year partnership with the Tour de France by supporting some of the best women athletes in the world. In addition, we hope our involvement will encourage more women to learn about career opportunities in transport, and the increasingly inclusive nature of our sector."

07:06 EDT ViewRay: Saitama Medical buys MRIdian MRI-Guided Radiation Therapy System - ViewRay announced that Saitama Medical University International Medical Center has purchased a MRIdian MRI-Guided Radiation Therapy System to complete its newly built comprehensive cancer center in Yamane, Hidaka-City. The MRIdian system will enable Saitama Medical University to offer advanced MRI-guided radiation therapy technology to cancer patients who are seeking personalized treatment for pancreas, prostate, lung, liver, breast, and oligometastatic cancers. Saitama Medical University International Medical Center is slated to install its MRIdian system in December 2022, with the first patient treatments beginning in early 2023. The center is eager to utilize MRIdian's real-time tracking and automated beam gating technology to support aggressive stereotactic body radiation therapy and treat complex cases. Indications of particular interest to Saitama Medical University researchers are pancreas and prostate, with a desire to participate in multi-centered international research hospital trials.

07:06 EDT Gencor Industries transfers common stock listing to NYSE American - Gencor Industries announced that it is transferring the listing of its common stock, $0.10 per share par value to the New York Stock Exchange American from the NASDAQ Global Market. The Company expects that listing and trading of its Common Stock on NASDAQ will end at market close on July 29, 2022 and that trading will commence on the NYSE American at the market open on August 1, 2022 under its current ticker symbol 'GENC'.

07:05 EDT GXO Logistics signs global agreement with 6 River Systems - GXO Logistics announced today that it has reached a multi-year global agreement with 6 River Systems, a leading fulfillment solutions provider, to meet the demand for Collaborative Mobile Robots, CMRs, in its logistics operations across the U.S. and Europe. "6 River Systems' Chucks provide a huge boost to the retention of our team members and deliver a substantial sustained increase in operational productivity," said Sandeep Sakharkar, Chief Information Officer at GXO. "This agreement fortifies our long-term partnership with 6RS, ensuring rapid deployment of popular productivity-enhancing warehouse collaborative robots that give our customers a competitive advantage."

07:04 EDT Neuronetics announces clearance from FDA for new indication for TMS system - Neuronetics announced clearance from the U.S. Food and Drug Administration, FDA, for a new indication for its transcranial magnetic stimulation, TMS, system - NeuroStar Advanced Therapy for Mental Health - to treat anxiety symptoms for adult patients who suffer from major depressive disorder, MDD, also known as anxious depression. "Today, we celebrate a big win for NeuroStar patients and providers," said Keith J. Sullivan, President and CEO of Neuronetics. "Many people suffering from MDD also experience anxiety symptoms, and these patients with anxious depression are more likely to be severely depressed and to have more thoughts of suicide. This new indication means providers can now describe to MDD patients the benefit of NeuroStar for improving their anxiety symptoms." The TrakStar results from 664 anxious depression patients demonstrated that 65.5% achieved a clinically meaningful response which exceeded the pre-established overall study success criteria of a minimum 50% response rate and indicated a large treatment effect size of 1.4.

07:03 EDT Avadel Pharmaceuticals announces tentative FDA approval of LUMRYZ - Avadel Pharmaceuticals announced that the U.S. Food and Drug Administration has granted tentative approval to LUMRYZ, also known as FT218. Tentative approval indicates that LUMRYZ has met all required quality, safety, and efficacy standards necessary for approval in the U.S. Final approval is pending disposition of U.S. Patent No. 8,731,963 which is listed in FDA's Orange Book. LUMRYZ is a once-at-bedtime investigational formulation of sodium oxybate for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. With tentative approval now secured, Avadel is continuing the following actions, including those that can potentially accelerate FDA's final approval decision and shorten the timeline between approval and launch of LUMRYZ: Filed a motion in the U.S. District Court for the District of Delaware on June 23, 2022, to delist the REMS patent from FDA's Orange Book. A court order requiring the patent holder to delist the REMS patent from the Orange Book could provide a pathway for a final approval of LUMRYZ prior to June 2023. Preparing for a claim construction hearing scheduled for August 31, 2022, that the Court previously stated is needed in order to rule on the pending patent delisting motion. Continuing key activities in anticipation of final approval, including planning for the final preparation of the LUMRYZ REMS program and the continued manufacturing of commercial supply. Based on extensive patient and physician research, Avadel estimates the total patient population could be greater than 30,000, and expects LUMRYZ, if approved, to be the treatment of choice for patients suffering from narcolepsy-related EDS or cataplexy. The current twice-nightly U.S. narcolepsy oxybate market is estimated at $1.8 billion comprised of approximately 16,000 patients. In addition, Avadel estimates that in the last three years, 10,000 - 15,000 patients have discontinued their twice-nightly oxybate use, many due to complications associated with middle of the night dosing. Furthermore, based on an analysis of U.S. claims data, the Company believes that each year approximately 3,000 patients initiate oxybate treatment for the first time and expects this to grow by 25-50% over time with the introduction of LUMRYZ.

07:02 EDT Steel Dynamics announces investment in low-carbon aluminum flat rolled mill - Steel Dynamics announced that its Board of Directors has authorized the company to construct and operate a 650,000-tonne low-carbon, recycled aluminum flat rolled mill, with two supporting satellite recycled aluminum slab centers. The capital investment is estimated to be $2.2B for the three facilities, and commercial production is planned to begin in the first quarter 2025. The state-of-the-art aluminum flat rolled mill will utilize a significant amount of aluminum scrap, and as such is also a complementary extension of the company's metals recycling platform, which is the largest nonferrous metals recycler in North America, the company said in a statement. The company estimates the project will generate between $650M-$700M of annual EBITDA on a through-cycle basis. The project will be funded with available cash and cash flow from operations, and the company plans to maintain its policy of strong shareholder distributions and investment grade credit ratings. The planned $1.9B aluminum flat rolled mill will be located in the Southeastern United States, with an annual production capacity of 650,000 tonnes of finished products, serving the sustainable beverage packaging, automotive, and common alloy industrial sectors.

07:01 EDT Clene receives positive EMA opinion on orphan drug designation for CNM-Au8 - Clene reported that it has received a positive opinion for its submission requesting Orphan Drug Designation for CNM-Au8 for the treatment of amyotrophic lateral sclerosis from the European Medicines Agency Committee for Orphan Medicinal Products.

07:00 EDT BHP Group sees FY23 Iron Ore output 249-260MT, down 2% to up 3% y/y - Sees FY23 Copper output 1,635-1,825kt, up 4%-16% y/y. Sees FY23 Metallurgical coal production 29-32MT, flat to up 10% y/y.

06:51 EDT Roche's Elecsys Amyloid Plasma Panel gets FDA breakthrough device designation - Roche announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to the Elecsys Amyloid Plasma Panel, which it calls "an innovative new solution to enable Alzheimer's disease to be detected earlier." The company said: "The Elecsys Amyloid Plasma Panel test detects and measures Alzheimer's disease biomarkers in blood plasma to indicate the need for further confirmatory testing for Alzheimer's disease. Roche is the first in-vitro diagnostics manufacturer to receive this designation for a blood-based biomarker test for Alzheimer's."

06:46 EDT Halliburton CEO says 'our strategy is working well' - "Our strong second quarter performance demonstrates that our strategy is working well, and Halliburton's strategic priorities are driving value. Total company revenue grew 18% sequentially, as activity increased simultaneously in North America and international markets, and adjusted operating income grew 35% with strong margin performance in both divisions," commented Jeff Miller, Chairman, President and CEO. "I expect the international markets will experience multiple years of growth, and I am confident that Halliburton is positioned to benefit more from this multi-year upcycle than ever before. We have a leading technology portfolio, the right geographic presence, and new service line opportunities that align perfectly with our strategy to deliver profitable international growth. In North America, I expect Halliburton to uniquely maximize value in this strong, steadily growing, and all but sold-out market. Pricing gains across all product service lines supported significant sequential margin expansion in the second quarter. Halliburton's competitive position is unique among our peers. We have the scale and technology to benefit meaningfully and differentially from the international market expansion, and we are the leader in the extremely busy North American market. I'm excited about the future of Halliburton and expect us to deliver profitable growth, margin expansion, strong free cash flow, and industry-leading returns in this upcycle," concluded Miller.

06:40 EDT TD Bank Group comments on expected impact of Charles Schwab's Q2 earnings - TD Bank Group (TD) announced that it expects The Charles Schwab Corporation's (SCHW) second quarter earnings to translate into approximately C$268M of reported equity in net income of an investment in Schwab for the Bank's fiscal 2022 third quarter. Excluding acquisition-related charges of approximately C$12M after-tax and amortization of acquired intangibles of approximately C$35M after-tax, adjusted equity in net income of an investment in Schwab will be approximately C$315M.

06:34 EDT Hasbro says 'making significant progress in our strategic plan review' - "The Hasbro team delivered strong second quarter results, driving mid-single digit revenue growth absent foreign exchange and 200 basis points of adjusted operating margin expansion," said Chris Cocks, Hasbro CEO. "Wizards of the Coast turned in its biggest quarter ever, led by 15% growth in tabletop gaming and 11% growth in MAGIC: THE GATHERING across platforms. We also significantly enhanced our digital play and direct-to-fan capabilities with the acquisition of D&D Beyond which will serve as an important growth driver for Hasbro's industry leading fantasy gaming portfolio" "We are making significant progress in our strategic plan review and are identifying and realizing cost savings across the business," continued Cocks. "Our teams are driving focus and scale in gaming, multi-generational brands and direct to consumer. Backed by Hasbro's unmatched portfolio of brands and brand-building capabilities, we have confidence in the strength of our initiatives for the second half and we are positioned to deliver profitable growth and long-term shareholder returns." "In the first half of the year, we took significant steps to secure inventory to help ensure product availability for upcoming product launches, major entertainment releases and the holiday season," said Deborah Thomas, Hasbro CFO. "Foreign exchange is impacting our top line revenue growth, but our teams are executing well to meet demand and drive profit. We successfully closed an acquisition supporting a key growing brand, returned cash to shareholders through dividends and share repurchases and anticipate higher operating cash generation in the second half of the year as our major new innovations and entertainment-driven initiatives come to market."

06:32 EDT Johnson & Johnson reports Q2 Consumer Health revenue down 1.3% at $3.8B - Reports Q2 Pharmaceuticals revenue up 6.7% y/y at $13.3B and MedTech revenue down 1.1% at $6.9B.

06:11 EDT Boeing announces 777 Partners orders up to 66 737 MAX jets - Boeing and 777 Partners announced a new order and commitment for up to 66 737 MAX jets, including a firm order for 30 ultra-efficient, high-capacity 737-8-200s. This is the U.S. investment firm's fifth order, rapidly building its portfolio to as many as 134 737 MAXs since 2021. The two companies announced the order with a signing ceremony at the Farnborough International Airshow.

06:08 EDT China Liberal Education receives noncompliance notification from Nasdaq - China Liberal Education announced that the company received a written notification from the Nasdaq on July 15, notifying the company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq.

06:03 EDT Universe Pharmaceuticals receives Nasdaq notice of non-compliance - Universe Pharmaceuticals announced that the company received a written notification from the Nasdaq Stock Market on July 15 notifying the company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the company's ordinary shares for the 30 consecutive business days from June 1 to July 14, the company no longer meets the minimum bid price requirement

05:53 EDT Tesla hit with lawsuit in Germany over car surveillance, Bloomberg reports - Tesla has been hit by a lawsuit in Germany over potential privacy concerns linked to its car surveillance cameras and claims that buying its vehicles helps cut CO2 emissions. VZBV, the main German consumer association that filed the action in a Berlin court on Tuesday, argues Tesla doesn't tell buyers that they must comply with European data regulations when using the sentry mode and that drivers may risk fines. Reference Link

05:33 EDT Kratos Defense to expand business unit in Birmingham - Kratos Defense announced plans to expand its newly established business unit in Birmingham, Alabama. With the support of enhancement programs provided by the State of Alabama, Jefferson County and the City of Birmingham, Kratos expects to add 76 jobs and make approximately $8.6M in capital investments in its Birmingham facility over the next five years. Kratos acquired the engineering division of Birmingham-based Southern Research in an $80less than asset transaction in May. The acquisition establishes Kratos SRE, an advanced concept group within Kratos' Defense & Rocket Support Services Division. SRE currently employs about 140 engineers, technicians and program support professionals conducting work in support of the space community, the Department of Defense and other national security customers.

05:31 EDT Incyte announces FDA approval for Opzelura cream 1.5% - Incyte announced that the FDA has approved Opzelura cream 1.5% for the topical treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older. Opzelura is the first and only FDA-approved treatment for repigmentation in patients with vitiligo, and the only topical formulation of a Janus kinase, or JAK, inhibitor approved in the United States. Vitiligo is a chronic autoimmune disease characterized by depigmentation of skin.

05:26 EDT Sinovac Biotech initiates trial for quadrivalent influenza vaccine in Chile - Sinovac Biotech announced that a phase III clinical trial for its inactivated quadrivalent influenza vaccine was initiated in the Republic of Chile through a collaboration with the Pontificia Universidad Catolica de Chile. Study results will provide scientific evidence to support Sinovac's influenza vaccine immunogenicity and protection capacity.

05:21 EDT AstraZeneca, Daiichi Sankyo announce Enhertu approval in the EU - Daiichi Sankyo and AstraZeneca's Enhertu has been approved in the European Union, or EU, as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive breast cancer who have received one or more prior anti-HER2-based regimens. Enhertu is a specifically engineered HER2 directed antibody drug conjugate, or ADC, being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.

05:16 EDT Triumph Group, Moog enter four-year MRO agreement - Triumph Group (TGI) and Moog (MOG) have entered into a four-year agreement to provide maintenance, repair and overhaul, or MRO, solutions for Boeing 787 landing gear and cargo door actuation control systems through Moog's Aftermarket Total Support Program, or MTS, for an Asia Pacific operator. This work will be performed at Triumph Actuation Products and Services hydraulic actuation centers of excellence in Yakima, Washington and Clemmons, North Carolina. Triumph is positioned as the OEM manufacturer of these 787 actuation products to provide the level of technical and customer MRO support.

05:11 EDT Lilium, AAP Aviation to develop eVTOL network in Scandinavia - Lilium has signed an agreement with AAP Aviation to develop an eVTOL network in Scandinavia. Under the agreement, AAP Aviation intends to purchase 40 Lilium Jets and collaborate with Lilium to identify and develop landing sites in the Scandinavian countries, starting with Norway. Together, AAP Aviation and Lilium plan to offer sustainable travel mobility to Scandinavia using the all-electric Lilium Jet, supplementing existing regional aircraft routes and ensuring low-emission travel between cities and communities. AAP Aviation and Lilium expect the market for on-demand aviation services to grow rapidly, pending authority approval of aircraft models and route infrastructure. The proposed arrangement between AAP Aviation and Lilium is subject to the parties finalizing commercial terms and entering into definitive agreements with respect thereto, and the satisfaction of certain conditions.